Cormorant Asset Management, LP — SEC Form 4 filings
SEC reporting owner CIK 1583977. 23 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2024-01-11 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 52 legs across 12 filings — 5,776,319 shares, $114,649,898 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 23 legs across 8 filings — 9,846,168 shares, $65,260,003 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 3,390,943 shares @ $7.58 ($25,703,348) in MoonLake Immunotherapeutics, filed 2025-10-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 10% owner | 5 | 31 legs · 1,932,632 sh · $53,693,261 | 1 leg · 30,029 sh · $344,012 | — |
| MoonLake Immunotherapeutics (MLTX) | — | 1 | — | 5 legs · 6,499,978 sh · $46,868,184 | — |
| EyePoint, Inc. (EYPT) | — | 4 | 6 legs · 2,286,765 sh · $37,622,267 | 1 leg · 60,000 sh · $942,240 | — |
| BRIGHT MINDS BIOSCIENCES INC. (DRUG) | — | 3 | 12 legs · 606,922 sh · $7,234,370 | 1 leg · 109,331 sh · $9,785,124 | — |
| BioAge Labs, Inc. (BIOA) | — | 1 | 1 leg · 450,000 sh · $8,100,000 | — | 2 |
| BlossomHill Therapeutics, Inc. (BLSM) | 10% owner | 1 | 1 leg · 312,500 sh · $5,000,000 | — | 5 |
| Immuneering Corp (IMRX) | 10% owner | 2 | — | 13 legs · 1,309,091 sh · $3,909,184 | — |
| OnKure Therapeutics, Inc. (OKUR) | — | 2 | — | 2 legs · 1,837,739 sh · $3,411,258 | — |
| Aardvark Therapeutics, Inc. (AARD) | — | 1 | 1 leg · 187,500 sh · $3,000,000 | — | 2 |
| Biomea Fusion, Inc. (BMEA) | — | 3 | — | — | 2 |
Form 4 filings — Cormorant Asset Management, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | BlossomHill Therapeutics, Inc. (BLSM) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund VI, LP | Conversion (C): 1,599,993 · Conversion (C): 1,701,541 · Purchase (P): 312,500 @ $16 · Grant/award (A): 23,904 (derivative) @ $0 · Conversion (C): 1,599,993 (derivative) · Conversion (C): 1,701,541 (derivative) | EDGAR |
| 2026-04-30 | 4 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP | Sale (S): 109,331 @ $89.50 | EDGAR |
| 2025-12-15 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Global Healthcare Master Fund, LP, Chen Bihua | Sale (S): 30,029 @ $11.46 | EDGAR |
| 2025-12-08 | 4 | EyePoint, Inc. (EYPT) jointly with Cormorant Global Healthcare Master Fund, LP, Chen Bihua | Sale (S): 60,000 @ $15.70 | EDGAR |
| 2025-10-01 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP | Sale (S): 70,748 @ $9.38 · Sale (S): 232,460 @ $8.40 · Sale (S): 3,390,943 @ $7.58 · Sale (S): 2,800,000 @ $6.61 · Sale (S): 5,827 @ $6.96 | EDGAR |
| 2025-08-01 | 4 | Biomea Fusion, Inc. (BMEA) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Holdings only — no transactions reported | EDGAR |
| 2025-06-13 | 4 | Biomea Fusion, Inc. (BMEA) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP, Chen Bihua | Sale (S): 1,813,439 @ $1.85 | EDGAR |
| 2025-05-14 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP, Chen Bihua | Sale (S): 24,300 @ $1.99 | EDGAR |
| 2025-02-19 | 4 | Aardvark Therapeutics, Inc. (AARD) jointly with Chen Bihua | Conversion (C): 800,189 · Purchase (P): 187,500 @ $16 · Conversion (C): 6,780,810 (derivative) | EDGAR |
| 2024-11-06 | 4 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) jointly with Chen Bihua | Purchase (P): 184,331 @ $21.70 | EDGAR |
| 2024-10-17 | 4 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) jointly with Cormorant Global Healthcare Master Fund, LP, Chen Bihua | Purchase (P): 238,097 @ $4.53 · Purchase (P): 63,173 @ $5.92 · Purchase (P): 33,343 @ $6.42 · Purchase (P): 8,900 @ $7.31 · Purchase (P): 2,600 @ $8.80 · Purchase (P): 2,700 @ $9.26 · +5 more | EDGAR |
| 2024-10-01 | 4 | BioAge Labs, Inc. (BIOA) jointly with Cormorant Private Healthcare Fund V LP, Chen Bihua, Cormorant Private Healthcare Fund IV LP | Conversion (C): 1,179,529 · Purchase (P): 450,000 @ $18 · Conversion (C): 5,263,772 (derivative) | EDGAR |
| 2024-09-24 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 45,085 @ $17.48 · Purchase (P): 25,943 @ $18.36 · Purchase (P): 66,088 @ $19.61 · Purchase (P): 139,551 @ $20.42 · Purchase (P): 47,564 @ $21.47 · Purchase (P): 25,769 @ $22.23 | EDGAR |
| 2024-06-13 | 4 | Biomea Fusion, Inc. (BMEA) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 642,847 @ $11.70 · Purchase (P): 207,153 @ $12.36 | EDGAR |
| 2024-04-22 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 395,244 @ $17.62 · Purchase (P): 186,521 @ $18.90 | EDGAR |
| 2024-04-03 | 4 | Immuneering Corp (IMRX) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Sale (S): 100 @ $3.07 · Sale (S): 300 @ $3.06 · Sale (S): 100 @ $3.05 · Sale (S): 600 @ $3.03 · Sale (S): 10 @ $3.01 · Sale (S): 10 @ $2.98 · +2 more | EDGAR |
| 2024-03-18 | 4 | Immuneering Corp (IMRX) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Sale (S): 345,266 @ $3.23 · Sale (S): 98,570 @ $4.25 · Sale (S): 54,215 @ $5.37 · Sale (S): 11,040 @ $5.97 · Sale (S): 400,000 @ $2.14 | EDGAR |
| 2024-03-11 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 46,799 @ $37.82 · Purchase (P): 10,736 @ $39.13 · Purchase (P): 90,325 @ $39.99 · Purchase (P): 102,140 @ $41.23 · Purchase (P): 29,342 @ $41.23 · Purchase (P): 24,983 @ $42.25 · +4 more | EDGAR |
| 2024-02-06 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Global Healthcare Master Fund, LP, Chen Bihua | Purchase (P): 750,000 @ $19 | EDGAR |
| 2024-01-30 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Global Healthcare Master Fund, LP, Chen Bihua | Purchase (P): 14,388 @ $25.73 · Purchase (P): 15,243 @ $26.66 · Purchase (P): 36,747 @ $27.70 · Purchase (P): 31,028 @ $28.82 · Purchase (P): 29,244 @ $29.42 · Purchase (P): 2,654 @ $31 · +8 more | EDGAR |
| 2024-01-11 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) jointly with Chen Bihua, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 105,000 @ $21.32 · Purchase (P): 750,000 @ $19.75 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1583977 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →